Home » Topics » Regulatory » Patents

Patents
RSS

Optically pure trimebutine metabolite useful for chronic pain

March 9, 1999

New radiolabeled cocaine analogues for diagnostic imaging designed at Emory University

March 9, 1999

Esteve patents novel compounds with multiple effects on the CNS

March 9, 1999

Agents for stimulating upper and lower GI motility in development at Labs. Jacques Logeais

March 9, 1999

Chemokine receptor modulators from Merck & Co. described in recent patent literature

March 8, 1999

Cyclooxygenase-inhibitory indoles under study at Pfizer

March 8, 1999

Merck discloses novel endothelin receptor antagonists

March 8, 1999

Muscarinic receptor modulators for psychotic disorders patented by Lilly

March 8, 1999

New anticancer agents from LG Chemical inhibit farnesyltransferase

March 8, 1999

Antithrombotic P2T antagonists in development at Astra

March 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...